Literature DB >> 12660806

Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12.

J Liu1, S H Juo, A Dewan, A Grunn, X Tong, M Brito, N Park, J E Loth, K Kanyas, B Lerer, J Endicott, G Penchaszadeh, J A Knowles, J Ott, T C Gilliam, M Baron.   

Abstract

Bipolar disorder (BP) is a severe and common psychiatric disorder characterized by extreme mood swings. Family, twin and adoption studies strongly support a genetic component. The mode of inheritance is complex and likely involves multiple, as yet unidentified genes. To identify susceptibility loci, we conducted a genome-wide scan with 343 microsatellite markers in one of the largest, well-characterized pedigree samples assembled to date (373 individuals in 40 pedigrees). To increase power to detect linkage, scan statistics were used to examine the logarithm of odds (lod) scores based on evidence at adjacent chromosomal loci. This analysis yielded significant evidence of linkage (genome-wide P&<0.05) for markers on 2p13-16. Standard linkage analysis was also supportive of linkage to 2p13-16 (lod=3.20), and identified several other interesting regions: 4q31 (lod=3.16), 7q34 (lod=2.78), 8q13 (lod=2.06), 9q31 (lod=2.07), 10q24 (lod=2.79), 13q32 (lod=2.2), 14q21 (lod=2.36) and 17q11-12 (lod=2.75). In this systematic, large-scale study, we identified novel putative loci for BP (on 2p13-16, 8q13 and 14q21) and found support for previously proposed loci (on 4q31, 7q34, 9q31, 10q21-24, 13q32 and 17q11-12). Two of the regions implicated in our study, 2p13-14 and 13q32, have also been linked to schizophrenia, suggesting that the two disorders may have susceptibility genes in common.

Entities:  

Mesh:

Year:  2003        PMID: 12660806     DOI: 10.1038/sj.mp.4001254

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  32 in total

1.  Genetics of major mood disorders.

Authors:  Wade Berrettini
Journal:  Psychiatry (Edgmont)       Date:  2004-09

Review 2.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

Review 3.  Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Authors:  R Parrish Waters; Marion Rivalan; D A Bangasser; J M Deussing; M Ising; S K Wood; F Holsboer; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2015-08-10       Impact factor: 8.989

4.  Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q.

Authors:  Matthew B McQueen; B Devlin; Stephen V Faraone; Vishwajit L Nimgaonkar; Pamela Sklar; Jordan W Smoller; Rami Abou Jamra; Margot Albus; Silviu-Alin Bacanu; Miron Baron; Thomas B Barrett; Wade Berrettini; Deborah Blacker; William Byerley; Sven Cichon; Willam Coryell; Nick Craddock; Mark J Daly; J Raymond Depaulo; Howard J Edenberg; Tatiana Foroud; Michael Gill; T Conrad Gilliam; Marian Hamshere; Ian Jones; Lisa Jones; Suh-Hang Juo; John R Kelsoe; David Lambert; Christoph Lange; Bernard Lerer; Jianjun Liu; Wolfgang Maier; James D Mackinnon; Melvin G McInnis; Francis J McMahon; Dennis L Murphy; Markus M Nothen; John I Nurnberger; Carlos N Pato; Michele T Pato; James B Potash; Peter Propping; Ann E Pulver; John P Rice; Marcella Rietschel; William Scheftner; Johannes Schumacher; Ricardo Segurado; Kristel Van Steen; Weiting Xie; Peter P Zandi; Nan M Laird
Journal:  Am J Hum Genet       Date:  2005-08-15       Impact factor: 11.025

5.  Genomewide scan and fine-mapping linkage studies in four European samples with bipolar affective disorder suggest a new susceptibility locus on chromosome 1p35-p36 and provides further evidence of loci on chromosome 4q31 and 6q24.

Authors:  Johannes Schumacher; Radka Kaneva; Rami Abou Jamra; Guillermo Orozco Diaz; Stephanie Ohlraun; Vihra Milanova; Young-Ae Lee; Fabio Rivas; Fermin Mayoral; Robert Fuerst; Antonia Flaquer; Christine Windemuth; Eudoxia Gay; Sebastian Sanz; Maria José González; Susana Gil; Francisco Cabaleiro; Francisco del Rio; Fermin Perez; Jesus Haro; Christian Kostov; Vesselin Chorbov; Amelia Nikolova-Hill; Vessela Stoyanova; George Onchev; Ivo Kremensky; Konstantin Strauch; Thomas G Schulze; Peter Nürnberg; Wolfgang Gaebel; Ansgar Klimke; Georg Auburger; Thomas F Wienker; Luba Kalaydjieva; Peter Propping; Sven Cichon; Assen Jablensky; Marcella Rietschel; Markus M Nöthen
Journal:  Am J Hum Genet       Date:  2005-11-02       Impact factor: 11.025

6.  Genomewide scan for affective disorder susceptibility Loci in families of a northern Swedish isolated population.

Authors:  Tine Venken; Stephan Claes; Samuel Sluijs; Andrew D Paterson; Cornelia van Duijn; Rolf Adolfsson; Jurgen Del-Favero; Christine Van Broeckhoven
Journal:  Am J Hum Genet       Date:  2004-12-21       Impact factor: 11.025

7.  Chromosome 13q13-q14 locus overlaps mood and psychotic disorders: the relevance for redefining phenotype.

Authors:  Michel Maziade; Yvon C Chagnon; Marc-André Roy; Alexandre Bureau; Alain Fournier; Chantal Mérette
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

Review 8.  Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder.

Authors:  Elena Ivleva; Gunvant Thaker; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2008-05-30       Impact factor: 9.306

Review 9.  The CRF system, stress, depression and anxiety-insights from human genetic studies.

Authors:  E B Binder; C B Nemeroff
Journal:  Mol Psychiatry       Date:  2009-12-15       Impact factor: 15.992

Review 10.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.